Recently, it has been reported that SARS-CoV-2 virus-specific T-cells were detected in the majority of COVID-19 patients, specifically the circulating SARS-CoV-2-specific CD8+ and CD4+ T cells in about 70% and 100% of COVID-19 convalescent patients, respectively [116]. The gene discussed is CD4; the disease is COVID-19.